Form 8-K Officer Departure
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): November 25, 2013
|
| | |
CVS CAREMARK CORPORATION |
(Exact Name of Registrant
as Specified in Charter) |
|
| Delaware | |
| (State or Other Jurisdiction of Incorporation) | |
|
001-01011 | | 05-0494040 |
(Commission File Number) | | (IRS Employer Identification No.) |
|
One CVS Drive Woonsocket, Rhode Island | | 2895 |
(Address of Principal Executive Offices) | | (Zip Code) |
|
| | |
Registrant’s telephone number, including area code: (401) 765-1500 |
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b) On November 25, 2013, CVS Caremark Corporation (the “Registrant”) announced that Mark S. Cosby, Executive Vice President, CVS Caremark Corporation and President - CVS/pharmacy, will be leaving employment with the Registrant effective December 31, 2013.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
| | | | |
| | CVS CAREMARK CORPORATION | |
| | | |
| | By: | /s/ David M. Denton |
| | | David M. Denton Executive Vice President and Chief Financial Officer |
| | | |
| | | Dated: November 25, 2013
|